Merck facilitated the social construction of the human papillomavirus as a problem needing treatment and successfully positioned Gardasil to be the solution to that problem.
Nicole Elizabeth Wolfe
July 19, 2010
In 2006, Gardasil, the first human papillomavirus (HPV) vaccine was approved by the Food and Drug Administration to protect women age 9-26 against four strains of HPV, 16, 18, 6, and 11 that cause 70 percent of cervical cancer cases and 90 percent of genital warts cases respectively.[Continue reading...]